Wang Qiu-Chen, Yuan Hua, Chen Zhi-Ming, Wang Jia, Xue Hui, Zhang Xiu-Ying
Jilin University, Changchun, P.R. China.
Clin Nurs Res. 2023 Jan;32(1):209-220. doi: 10.1177/10547738221104216. Epub 2022 Jun 16.
This study aims to synthesize the barriers and facilitators of oral nutritional supplement adherence in people with cancer and assess levels of adherence. Databases including Embase, PubMed, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang Database, and Chinese Scientific Journal Database, were used to search articles before January 4, 2021. Eighteen studies with 1,267 participants met the inclusion criteria. All studies reported rates of adherence, ranging from 6.0% to 96.9%. Gastrointestinal intolerances and disliked tastes were considered common barriers to cancer patients' adherence, whereas the ONS management strategy was considered the most crucial facilitator of adherence. Health professionals can improve adherence through regular monitoring and guidance and incentive strategies, and paying attention to the management and prevention of adverse reactions when prescribing nutritional products.
本研究旨在综合分析癌症患者口服营养补充剂依从性的障碍和促进因素，并评估依从水平。使用包括Embase、PubMed、Web of Science、Cochrane图书馆、中国知网、万方数据库和中国科学期刊数据库在内的数据库检索2021年1月4日前的文章。18项研究共1267名参与者符合纳入标准。所有研究均报告了依从率，范围为6.0%至96.9%。胃肠道不耐受和口味不佳被认为是癌症患者依从性的常见障碍，而口服营养补充剂管理策略被认为是依从性最关键的促进因素。卫生专业人员可通过定期监测、指导和激励策略提高依从性，并在开具营养产品处方时注意不良反应的管理和预防。
